JP2023529011A5 - - Google Patents
Info
- Publication number
- JP2023529011A5 JP2023529011A5 JP2022576471A JP2022576471A JP2023529011A5 JP 2023529011 A5 JP2023529011 A5 JP 2023529011A5 JP 2022576471 A JP2022576471 A JP 2022576471A JP 2022576471 A JP2022576471 A JP 2022576471A JP 2023529011 A5 JP2023529011 A5 JP 2023529011A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- inden
- methylidene
- phenyl
- fluoro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063038737P | 2020-06-12 | 2020-06-12 | |
| US63/038,737 | 2020-06-12 | ||
| PCT/CN2021/099626 WO2021249529A1 (en) | 2020-06-12 | 2021-06-11 | Indene compounds, pharmaceutical compositions thereof, and their therapeutic applications |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023529011A JP2023529011A (ja) | 2023-07-06 |
| JP2023529011A5 true JP2023529011A5 (https=) | 2024-09-24 |
Family
ID=78846886
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022576471A Pending JP2023529011A (ja) | 2020-06-12 | 2021-06-11 | インデン化合物、その医薬組成物、及びそれらの治療応用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230234909A1 (https=) |
| EP (1) | EP4165009A4 (https=) |
| JP (1) | JP2023529011A (https=) |
| KR (1) | KR20230024976A (https=) |
| CN (1) | CN116472034B (https=) |
| AU (1) | AU2021287932A1 (https=) |
| CA (1) | CA3182036A1 (https=) |
| IL (1) | IL298984A (https=) |
| TW (1) | TW202214555A (https=) |
| WO (1) | WO2021249529A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117916215A (zh) * | 2021-05-15 | 2024-04-19 | 藤济(厦门)生物医药科技有限公司 | 茚化合物、其药物组合物及其治疗应用 |
| CN120513226A (zh) * | 2022-11-16 | 2025-08-19 | 藤济(厦门)生物医药科技有限公司 | 茚化合物、其药物组合物及其治疗应用 |
| CN116589404A (zh) * | 2023-04-24 | 2023-08-15 | 华南理工大学 | 一种靶向β淀粉样蛋白的光敏剂及其制备方法与应用 |
| WO2025051192A1 (en) * | 2023-09-06 | 2025-03-13 | Nucmito Pharmaceuticals Company Limited | Rxr-alpha modulators for treating malignancy |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6214876B1 (en) * | 1994-07-21 | 2001-04-10 | Eli Lilly And Company | Indene-1-acetamide sPLA2 inhibitors |
| JP2002511852A (ja) * | 1997-05-07 | 2002-04-16 | スージェン・インコーポレーテッド | 蛋白質キナーゼ活性の調節剤としての２−インドリノン誘導体 |
| AU9664198A (en) * | 1997-09-26 | 1999-04-23 | Eli Lilly And Company | Method for the treatment of cystic fibrosis |
| DE10163426A1 (de) * | 2001-12-21 | 2003-07-03 | Max Planck Gesellschaft | Pharmakologisch wirksame Inden-Derivate |
| CA2712017C (en) * | 2008-01-18 | 2016-08-09 | Oxagen Limited | Compounds having crth2 antagonist activity |
| JP2013533212A (ja) * | 2010-05-06 | 2013-08-22 | サンフォード−バーナム メディカル リサーチ インスティテュート | レチノイド受容体に選択的な経路に関する方法および組成物 |
-
2021
- 2021-06-11 US US18/001,309 patent/US20230234909A1/en active Pending
- 2021-06-11 TW TW110121344A patent/TW202214555A/zh unknown
- 2021-06-11 IL IL298984A patent/IL298984A/en unknown
- 2021-06-11 WO PCT/CN2021/099626 patent/WO2021249529A1/en not_active Ceased
- 2021-06-11 JP JP2022576471A patent/JP2023529011A/ja active Pending
- 2021-06-11 AU AU2021287932A patent/AU2021287932A1/en active Pending
- 2021-06-11 KR KR1020237001096A patent/KR20230024976A/ko active Pending
- 2021-06-11 EP EP21822474.9A patent/EP4165009A4/en active Pending
- 2021-06-11 CN CN202180055583.6A patent/CN116472034B/zh active Active
- 2021-06-11 CA CA3182036A patent/CA3182036A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023529011A5 (https=) | ||
| JP2019077725A5 (https=) | ||
| EA035256B1 (ru) | Ингибиторы аутотаксинов, содержащие гетероарил-бензил-амидное ядро | |
| JP2014516360A5 (https=) | ||
| JP2009507011A5 (https=) | ||
| US20150274653A1 (en) | Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis b | |
| JP2010518026A5 (https=) | ||
| JP2022546717A (ja) | Ｕｓｐ３０阻害剤としての活性を有する置換シアノピロリジン類 | |
| RU2005131165A (ru) | Производные имидазол-4-илэтинилпиридина | |
| JP2019532052A5 (https=) | ||
| JP2006510609A5 (https=) | ||
| JP2014510695A5 (https=) | ||
| JP2024500377A5 (https=) | ||
| JP2016540811A5 (https=) | ||
| JP2017537937A (ja) | 線維症の小分子阻害剤 | |
| NZ552501A (en) | Novel cyclic aminobenzoic acid derivative | |
| JP2024542248A5 (https=) | ||
| JP2010504321A5 (https=) | ||
| RU2715241C2 (ru) | (2r,4r)-5-(5′-хлор-2′-фторбифенил-4-ил)-2-гидрокси-4-[(5-метилоксазол-2-карбонил)амино]пентановая кислота | |
| JP2013522372A5 (https=) | ||
| US9242971B2 (en) | Compounds for the treatment of conditions associated with DGAT1 activity | |
| RU2010151475A (ru) | Ингибиторы jnk | |
| AU2018321287A1 (en) | Azole analogues and methods of use thereof | |
| EP4038052A2 (en) | Prostaglandin e2 (pge2) ep4 receptor antagonists | |
| JP2022554330A5 (https=) |